Kolamunnage-Dona R, Berhane S, Potts H, Williams EH, et al. Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma. J Hepatol 2021 May 27. pii: S0168-8278(21)00350.
PMID: 34052255